ALNYLAM PHARMACEUTICALS INC (ALNY)

13F ownership of ALNYLAM PHARMACEUTICALS INC among the superinvestors tracked on fructus.finance, based on their latest quarterly SEC filings.

Price history

Loading...
Tracked holders
3
Combined value
$100M
New buyers this quarter
2

Superinvestors holding ALNY

K
Ken Griffin
Citadel Advisors LLC · Q2 2026
$58M
0.01% of portfolio
New buy
R
Ray Dalio
Bridgewater Associates, LP · Q2 2026
$30M
0.12% of portfolio (-6.6%)
Trimmed
J
Joel Greenblatt
Gotham Asset Management, LLC · Q2 2026
$13M
0.03% of portfolio
New buy

Based on 13F filings submitted to the SEC, published with roughly 45 days of lag. Only long equity positions are captured. See our guide on how to read a 13F filing for more context, or browse the full superinvestor consensus.